glp 1 tirzepatide vs semaglutide Semaglutide: Weight Loss, Side Effects & Cost (2026) Troubling Findings in Study of

Deanfields findings led to media coverage on the potential wider benefits of semaglutide, including a front-page story in The Times in which he claimed: a large number of potential patients who have cardiovascular disease would benefit from use of this drug

In one large study, people who had stopped the medication regained around two-thirds of the weight they had lost within a year

PMID: 33200892 Iorga RA, Bacalbasa N, Carsote M, Bratu OG, Stanescu AMA, Bungau S, Pantis C, Diaconu CC (2020) Metabolic and cardiovascular benefits of GLP-1 agonists, besides the hypoglycemic effect (Review)

The study suggested that even pasteurized (heat-treated) Akkermansia retained beneficial metabolic properties